TrialAnalytical cellular pathology (Amsterdam)2020

Efficacy and Safety of Rivaroxaban versus Warfarin for the Treatment of Acute Pulmonary Embolism: A Real-World Study.

Yan Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.